Royal Bank Of Canada Ionis Pharmaceuticals Inc Transaction History

Royal Bank Of Canada

$471 Billion
Q3 2024

A detailed history of Royal Bank Of Canada transactions in Ionis Pharmaceuticals Inc stock. As of the latest transaction made, Royal Bank Of Canada holds 670,149 shares of IONS stock, worth $23.7 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

670,149

Previous 678,360 1.21%

Holding current value

$23.7 Million

Previous $32.3 Million 16.96%

% of portfolio

0.01%

Previous 0.01%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$40.06 - $51.86 $328,932 - $425,822	-8,211 Reduced 1.21%	670,149 $26.8 Million
Q2 2024 Aug 14, 2024	SELL	$36.45 - $47.7 $1.96 Million - $2.57 Million	-53,877 Reduced 7.36%	678,360 $32.3 Million
Q1 2024 Nov 05, 2024	BUY	$42.03 - $53.55 $2.26 Million - $2.89 Million	53,877 Added 7.94%	732,237 $31.7 Million
Q1 2024 May 15, 2024	SELL	$42.03 - $53.55 $1.77 Million - $2.25 Million	-42,009 Reduced 5.43%	732,237 $31.7 Million
Q4 2023 Feb 14, 2024	BUY	$43.39 - $51.63 $4.81 Million - $5.72 Million	110,802 Added 16.7%	774,246 $39.2 Million
Q3 2023 Nov 14, 2023	BUY	$38.5 - $47.13 $3.32 Million - $4.07 Million	86,306 Added 14.95%	663,444 $30.1 Million
Q2 2023 Aug 14, 2023	BUY	$34.73 - $43.33 $2.82 Million - $3.52 Million	81,181 Added 16.37%	577,138 $23.7 Million
Q1 2023 May 15, 2023	SELL	$33.58 - $41.2 $365,619 - $448,585	-10,888 Reduced 2.15%	495,957 $17.7 Million
Q4 2022 Feb 14, 2023	BUY	$37.12 - $46.52 $2.6 Million - $3.26 Million	70,021 Added 16.03%	506,845 $19.1 Million
Q3 2022 Nov 14, 2022	BUY	$36.54 - $48.66 $306,972 - $408,792	8,401 Added 1.96%	436,824 $19.3 Million
Q2 2022 Aug 15, 2022	SELL	$31.71 - $43.0 $509,865 - $691,397	-16,079 Reduced 3.62%	428,423 $15.9 Million
Q1 2022 May 16, 2022	SELL	$29.88 - $37.04 $1.08 Million - $1.34 Million	-36,146 Reduced 7.52%	444,502 $16.5 Million
Q4 2021 Feb 14, 2022	SELL	$25.61 - $35.1 $228,261 - $312,846	-8,913 Reduced 1.82%	480,648 $14.6 Million
Q3 2021 Nov 15, 2021	BUY	$33.54 - $40.55 $154,116 - $186,327	4,595 Added 0.95%	489,561 $16.4 Million
Q2 2021 Aug 16, 2021	BUY	$34.54 - $47.25 $16.8 Million - $22.9 Million	484,966 New	484,966 $19.3 Million

Others Institutions Holding IONS

# of Institutions

404

Shares Held

136M

Call Options Held

862K

Put Options Held

582K

View Full List

About IONIS PHARMACEUTICALS INC

Ticker IONS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,940,992
Market Cap $5.02B
Description
Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...

More about IONS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

News

Stay updated on Royal Bank Of Canada with notifications on news.

Account

Royal Bank Of Canada Ionis Pharmaceuticals Inc Transaction History